# Dong‑Hoon Lee

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/donghoon-lee
Canonical HTML page: https://getbiobrief.com/entity/donghoon-lee

## Recent coverage (1 stories)

### Insilico's $2.5B AI CNS Biobucks Deal With SK Bio Sets APAC Record
2026-06-23 04:57:27 · Sentiment: Strongly positive · Impact: 8/10 · Sources: 2

In the largest Asia‑Pacific licensing deal for Insilico Medicine, the AI‑first biotech secured up to $2.5 billion in milestones plus royalties from South Korea's SK Biopharmaceuticals, a CNS powerhouse, to co‑develop next‑generation neuroimmune therapies. The heavily back‑ended structure reflects industry‑standard risk‑sharing, with Insilico taking $18M up front and SK steering commercialization, underscoring a growing appetite for AI‑discovered assets in big pharma pipelines.
Full story: https://getbiobrief.com/story/insilico-sk-biopharma-2-5b-biobucks-record-apac

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.